Johnson & Johnson's ECNIS PureSee IOL Gets FDA's Approval For Use In Cataract Surgery
unknown
📅 Published: 2026-03-12 08:04
📰 Source: Benzinga
📝 Words: 33
📝 Article Content
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract surgery.1 TECNIS
📄 Summary
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract surgery.1 TECNIS
Scraping Metadata:
Scraped At:
Unknown
Created At:
2026-03-13 18:10:35
Updated At:
2026-03-13 18:10:35
Scraping Job ID:
N/A
Stock Mentions:
JNJ - Johnson & Johnson
Relevance: N/A
AMP - Ameriprise Financial Inc.
Relevance: N/A